Company: ICUI
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0000883984-25-000035
Chunk: 44

Company: ICU MEDICAL INC/DE
Filing Date: 2025-11-06
Form: 10-Q
Item: Item 1
Chunk 44
---
 — none— — Common stock, $0.10 par value; Authorized — 80,000 shares; Issued — 24,686 shares at September 30, 2025 and 24,518 shares at December 31, 2024; and outstanding — 24,686 shares at September 30, 2025 and 24,517 shares at December 31, 20242,469 2,452 Additional paid-in capital1,451,146 1,412,118 Treasury stock, at cost (99 shares at September 30, 2025 and 571 shares at December 31, 2024)(12)(92)Retained earnings706,624 690,158 Accumulated other comprehensive loss(32,977)(139,401)TOTAL STOCKHOLDERS' EQUITY2,127,250 1,965,235 TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY$4,102,896 $4,203,931 

______________________________________________________

(1) December 31, 2024 balances were derived from audited consolidated financial statements.

The accompanying notes are an integral part of these condensed consolidated financial statements.

3

Table of Contents

ICU MEDICAL, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

(In thousands, except per share data)

 Three months ended September 30,Nine months ended September 30, 2025202420252024TOTAL REVENUES$536,990 $589,131 $1,690,558 $1,752,241 COST OF GOODS SOLD336,109 384,279 1,071,504 1,154,717 GROSS PROFIT200,881 204,852 619,054 597,524 OPERATING EXPENSES:  Selling, general and administrative152,773 162,707 469,398 479,913 Research and development21,251 21,028 66,409 66,260 Restructuring, strategic transaction and integration13,138 16,828 46,053 50,069 Change in fair value of contingent earn-out— (3,947)— (3,991)TOTAL OPERATING EXPENSES187,162 196,616 581,860 592,251 IN